Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaen
dc.date.accessioned2013-11-15T16:07:52Z
dc.date.available2013-11-15T16:07:52Z
dc.date.issued2013
dc.identifier.govdocWHO/HIV/2013.84
dc.identifier.urihttps://apps.who.int/iris/handle/10665/94593
dc.description12 p.en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subject.meshHIV Infections
dc.subject.meshHepatitis C
dc.subject.meshHepatitis B
dc.subject.meshCoinfection
dc.subject.meshAnti-Retroviral Agents
dc.subject.meshSouth Africa
dc.titleAPPENDIX: Modelling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africaen
dc.typeTechnical documentsen
dc.subject.meshqualifierdrug therapy
dc.subject.meshqualifiertherapeutic use


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record